{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:12:23Z","timestamp":1789823543916,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874735"],"award-info":[{"award-number":["874735"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006319","name":"Centre National pour la Recherche Scientifique et Technique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e38587","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:43:57Z","timestamp":1727459037000},"page":"e38587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["N-alkylation of amines for the synthesis of potential antiviral agents: A structural modification approach"],"prefix":"10.1016","volume":"10","author":[{"given":"Nadia","family":"Arrousse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0610-8218","authenticated-orcid":false,"given":"Elyor","family":"Berdimurodov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Bogacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathiah","family":"Zakham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soukaina","family":"Esslali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sghir","family":"EL Kadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vapalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.heliyon.2024.e38587_bib1","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209514119","article-title":"SARS-CoV-2 requires acidic pH to infect cells","volume":"119","author":"Kreutzberger","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38587_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40199-022-00446-8","article-title":"A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines","volume":"30","author":"Abdolmaleki","year":"2022","journal-title":"Daru"},{"key":"10.1016\/j.heliyon.2024.e38587_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38587_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2024.e38587_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.heliyon.2024.e38587_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.129891","article-title":"Inhibitory capacity of Chloroquine against SARS-COV-2 by effective binding with Angiotensin converting enzyme-2 receptor: an insight from molecular docking and MD-simulation studies","volume":"1230","author":"Baildya","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38587_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell discovery"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38587_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Bioscience trends"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38587_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2024.e38587_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2022.100243","article-title":"Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE\u2013Coalition V): a double-blind, multicentre, randomised, controlled trial","volume":"11","author":"Avezum","year":"2022","journal-title":"The Lancet Regional Health\u2013Americas"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e38587_bib11","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2020.16253","article-title":"Emergency use authorizations during the COVID-19 pandemic: lessons from hydroxychloroquine for vaccine authorization and approval","volume":"324","author":"Thomson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e38587_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2022.100268","article-title":"Hydroxychloroquine for COVID19: the curtains close on a comedy of errors","volume":"11","author":"Schwartz","year":"2022","journal-title":"The Lancet Regional Health\u2013Americas"},{"key":"10.1016\/j.heliyon.2024.e38587_bib13","series-title":"Hydroxychloroquine and Chloroquine Retinopathy","author":"Browning","year":"2014"},{"issue":"42","key":"10.1016\/j.heliyon.2024.e38587_bib14","doi-asserted-by":"crossref","first-page":"59570","DOI":"10.1007\/s11356-021-16096-3","article-title":"Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis","volume":"28","author":"Biswas","year":"2021","journal-title":"Environ. Sci. Pollut. Control Ser."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38587_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7861\/clinmed.2020-0129","article-title":"Chloroquine and COVID-19\u2013a potential game changer?","volume":"20","author":"Sturrock","year":"2020","journal-title":"Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e38587_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/PL00020731","article-title":"Heterocyclic nitro compounds. 25. 1-Hydroxymethyl-3-nitro-1, 2, 4-triazoles and their derivatives","volume":"16","author":"Pevzner","year":"1980","journal-title":"Chem. Heterocycl. Compd."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38587_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.00902-21","article-title":"A generic, scalable, and rapid time-resolved F\u00f6rster resonance energy transfer-based assay for antigen detection\u2014SARS-CoV-2 as a proof of concept","volume":"12","author":"Rusanen","year":"2021","journal-title":"mBio"},{"issue":"6518","key":"10.1016\/j.heliyon.2024.e38587_bib18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38587_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2021.01.015","article-title":"Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response","volume":"29","author":"Lin","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38587_bib20","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.heliyon.2024.e38587_bib21","first-page":"1","article-title":"Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints","author":"Rudrapal","year":"2024","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38587_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22668-1","article-title":"Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy","volume":"12","author":"Issahaku","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38587_bib23","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1038\/s41598-023-35161-0","article-title":"Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies","volume":"13","author":"Rudrapal","year":"2023","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e38587_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202300277","article-title":"Discovery of potential KRAS\u2010SOS1 inhibitors from South African natural compounds: an in silico approach","volume":"8","author":"Issahaku","year":"2023","journal-title":"ChemistrySelect"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38587_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202103908","article-title":"Design, synthesis, molecular docking, molecular dynamics and in vivo antimalarial activity of new dipeptide\u2010sulfonamides","volume":"7","author":"Ezugwu","year":"2022","journal-title":"ChemistrySelect"},{"issue":"suppl_1","key":"10.1016\/j.heliyon.2024.e38587_bib26","doi-asserted-by":"crossref","first-page":"D302","DOI":"10.1093\/nar\/gkj120","article-title":"The RCSB PDB information portal for structural genomics","volume":"34","author":"Kouranov","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38587_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06605","article-title":"Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors","volume":"7","author":"Moussa","year":"2021","journal-title":"Heliyon"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e38587_bib29","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1080\/07391102.2020.1805019","article-title":"Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19","volume":"39","author":"Lokhande","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e38587_bib30","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/08927022.2022.2110246","article-title":"Molecular modelling of antiproliferative inhibitors based on SMILES descriptors using Monte-Carlo method, docking, MD simulations and ADME\/Tox studies","volume":"48","author":"Tabti","year":"2022","journal-title":"Mol. Simulat."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e38587_bib31","article-title":"QSAR, molecular docking, ADMET properties in silico studies for a series of 7-propanamide benzoxaboroles as potent anti-cancer agents","volume":"50","author":"Mohammed","year":"2022","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e38587_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jtice.2020.08.028","article-title":"Investigation of pyrimidine analogues as xanthine oxidase inhibitors to treat of hyperuricemia and gout through combined QSAR techniques, molecular docking and molecular dynamics simulations","volume":"113","author":"Abdizadeh","year":"2020","journal-title":"J. Taiwan Inst. Chem. Eng."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402414618X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402414618X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:49:59Z","timestamp":1789822199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402414618X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S240584402414618X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38587","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-alkylation of amines for the synthesis of potential antiviral agents: A structural modification approach","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38587"}}